APOE and Parkinson disease: Therefore, this study allows us to conclude that APOE polymorphism does not distinguish PD patients from Controls, as opposed to the lipid profile alone or in association with APOE. In this case, and increase in TC and LDLc levels can be observed in PD patients, whereas higher VLDLc and TG levels are prevalent in Controls.